⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2143671 | 1.00 | — | — | |
| SCHEMBL8255211 | 1.00 | — | — | |
| SCHEMBL16882865 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL11467758 | 0.96 | — | — | |
| SCHEMBL15916987 | 0.87 | — | — | |
| SCHEMBL13939764 | 0.85 | CHRNB2 (0.36) | — | |
| SCHEMBL23267575 | 0.84 | CHRNA7 (0.33) | — | |
| SCHEMBL2271063 | 0.84 | CHRNA7 (0.33) | — | |
| SCHEMBL13849461 | 0.84 | CHRNA7 (0.33) | — | |
| SCHEMBL22270766 | 0.83 | CHRNB2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023196283-A1 | EGFR INHIBITORS | BLUEPRINT MEDICINES CORPORATION (US) | 2023-10-12 | — | — | WO | disclosed |
| WO-2023036140-A1 | 3CLPRO PROTEASE INHIBITOR | 上海齐鲁制药研究中心有限公司 | 2023-03-16 | — | — | WO | disclosed |
| WO-2020150372-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS | CURZA GLOBAL, LLC (US) | 2020-07-23 | — | — | WO | disclosed |
| EP-3099695-B1 | COMPOUNDS | GLAXOSMITHKLINE IP DEV LTD (GB) | 2020-04-08 | — | — | EP | disclosed |